Risk and Management of Hypertension in Cancer Patient Undergoing Targeted Therapy

Dates and Times

Start: 2/1/2023 8:00 AM
End: 2/1/2023 9:00 AM

Objectives

•Risk of HTN in patients undergoing targeted therapies

•Mechanisms of HTN induced by targeted therapies

•General management of HTN induced by targeted therapies

•Bases for individualized HTN treatment in this population

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.